Derek L Vanhille, MD | |
1551 Renaissance Towne Dr Ste 310, Bountiful, UT 84010-7671 | |
(801) 295-5581 | |
(801) 295-9253 |
Full Name | Derek L Vanhille |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 10 Years |
Location | 1551 Renaissance Towne Dr Ste 310, Bountiful, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205254885 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 11163441-1205 (Utah) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mountain View Hospital | Payson, UT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Central Utah Clinic Pc | 7517868508 | 391 |
News Archive
In honor of 2009 World No Tobacco Day Nigerian Heart Foundation President Oluyomi Adeyemi-Wilson spoke at an event in Lagos, Nigeria, on Sunday where he called for members of the National Assembly to pass a new bill requiring that cigarette manufacturers print pictorial and graphical health warnings on the packages of cigarettes - an effort supported by the WHO, Vanguard/allAfrica.com reports.
Alzheimer's disease is progressive, but slow to develop - or at least to reveal itself. In a new study, published online February 14, 2020 in the journal Biological Psychiatry, researchers at University of California San Diego School of Medicine, with colleagues elsewhere, report that early, subtle differences in cognitive performance, such as fewer words recalled on a memory test, are a sign that harmful proteins are accumulating in the brain, even if levels of those proteins do not yet qualify as dangerous.
A couple stories Friday examine just how Americans ended up with a system where employers pick up the tab for health insurance and which groups will end up paying more for health reform.
The Minneapolis Medical Research Foundation at Hennepin County Medical Center (HCMC) is pleased to announce that it has earned full accreditation from the Association for the Accreditation of Human Research Protection Programs.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
› Verified 4 days ago
Entity Name | Central Utah Clinic Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093764805 PECOS PAC ID: 7517868508 Enrollment ID: O20040113000805 |
News Archive
In honor of 2009 World No Tobacco Day Nigerian Heart Foundation President Oluyomi Adeyemi-Wilson spoke at an event in Lagos, Nigeria, on Sunday where he called for members of the National Assembly to pass a new bill requiring that cigarette manufacturers print pictorial and graphical health warnings on the packages of cigarettes - an effort supported by the WHO, Vanguard/allAfrica.com reports.
Alzheimer's disease is progressive, but slow to develop - or at least to reveal itself. In a new study, published online February 14, 2020 in the journal Biological Psychiatry, researchers at University of California San Diego School of Medicine, with colleagues elsewhere, report that early, subtle differences in cognitive performance, such as fewer words recalled on a memory test, are a sign that harmful proteins are accumulating in the brain, even if levels of those proteins do not yet qualify as dangerous.
A couple stories Friday examine just how Americans ended up with a system where employers pick up the tab for health insurance and which groups will end up paying more for health reform.
The Minneapolis Medical Research Foundation at Hennepin County Medical Center (HCMC) is pleased to announce that it has earned full accreditation from the Association for the Accreditation of Human Research Protection Programs.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Derek L Vanhille, MD Po Box 5546, Denver, CO 80217-5546 Ph: (801) 475-3500 | Derek L Vanhille, MD 1551 Renaissance Towne Dr Ste 310, Bountiful, UT 84010-7671 Ph: (801) 295-5581 |
News Archive
In honor of 2009 World No Tobacco Day Nigerian Heart Foundation President Oluyomi Adeyemi-Wilson spoke at an event in Lagos, Nigeria, on Sunday where he called for members of the National Assembly to pass a new bill requiring that cigarette manufacturers print pictorial and graphical health warnings on the packages of cigarettes - an effort supported by the WHO, Vanguard/allAfrica.com reports.
Alzheimer's disease is progressive, but slow to develop - or at least to reveal itself. In a new study, published online February 14, 2020 in the journal Biological Psychiatry, researchers at University of California San Diego School of Medicine, with colleagues elsewhere, report that early, subtle differences in cognitive performance, such as fewer words recalled on a memory test, are a sign that harmful proteins are accumulating in the brain, even if levels of those proteins do not yet qualify as dangerous.
A couple stories Friday examine just how Americans ended up with a system where employers pick up the tab for health insurance and which groups will end up paying more for health reform.
The Minneapolis Medical Research Foundation at Hennepin County Medical Center (HCMC) is pleased to announce that it has earned full accreditation from the Association for the Accreditation of Human Research Protection Programs.
Delcath Systems, Inc., a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the U.S. Food & Drug Administration granted Delcath's request for orphan drug designation for doxorubicin for the treatment of hepatocellular carcinoma (HCC), also known as primary liver cancer. Clinicians in the U.S. diagnose nearly 20,000 cases of HCC annually.
› Verified 4 days ago
Curt Robert Stock, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1551 Renaissance Towne Dr, Suite 310, Bountiful, UT 84010 Phone: 801-295-5581 Fax: 801-295-9253 | |
Dr. Joshua Brian Bradshaw, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1551 Renaissance Towne Dr Ste 310, Bountiful, UT 84010 Phone: 801-295-5581 Fax: 801-295-9253 | |
Dr. Demetrios Gregory Skedros, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1551 Renaissance Towne Dr, Suite 310, Bountiful, UT 84010 Phone: 801-295-5581 Fax: 801-295-9253 | |
Dr. Steven Michael Kelly, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1551 Renaissance Towne Dr, Suite 310, Bountiful, UT 84010 Phone: 801-295-5581 Fax: 801-295-9253 |